Historical salary details - Mr. David W.J. McGirr, M.B.A., Independent Director, Insmed Inc
Mr. David W.J. McGirr, M.B.A. is the Independent Director of Insmed Inc. They also hold 2 other positions in X4 Pharmaceuticals Inc and Rhythm Pharmaceuticals Inc..
Mr. David W.J. Mcgirr, M.B.A.
Independent Director
$ 410 K
Gross Remuneration
-
Current Company
Insmed Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Insmed Inc | Independent Director | 410 K | - |
| 2024 | X4 Pharmaceuticals Inc | Independent Director | - | - |
| 2024 | Rhythm Pharmaceuticals Inc. | Independent Director | - | - |
| 2023 | Rhythm Pharmaceuticals Inc. | Independent Director | 308.8 K | 145.3 % |
| 2023 | Insmed Inc | Independent Director | - | - |
| 2022 | Insmed Inc | Independent Director | 320 K | 18.5 % |
| 2022 | Rhythm Pharmaceuticals Inc. | Independent Director | 125.9 K | -48.9 % |
| 2022 | X4 Pharmaceuticals Inc | Independent Director | 61.7 K | -35.8 % |
| 2021 | Insmed Inc | Independent Director | 270 K | 0.0 % |
| 2021 | Rhythm Pharmaceuticals Inc. | Independent Director | 246.6 K | -16.4 % |
| 2021 | X4 Pharmaceuticals Inc | Independent Director | 96.2 K | 27.1 % |
| 2020 | Rhythm Pharmaceuticals Inc. | Independent Director | 294.9 K | 13.1 % |
| 2020 | Insmed Inc | Independent Director | 270 K | 0.0 % |
| 2020 | X4 Pharmaceuticals Inc | Independent Director | 75.7 K | -13.9 % |
| 2020 | VYNE Therapeutics Inc | - | 11.8 K | -91.9 % |
| 2020 | VYNE Therapeutics Inc | Independent Director | - | - |
| 2019 | Insmed Inc | Independent Director | 270 K | 20.0 % |
| 2019 | Rhythm Pharmaceuticals Inc. | Independent Director | 260.8 K | 2.1 % |
| 2019 | VYNE Therapeutics Inc | Independent Director | 145.9 K | 137.0 % |
| 2019 | X4 Pharmaceuticals Inc | Independent Director | 87.9 K | -47.7 % |
| 2018 | Rhythm Pharmaceuticals Inc. | Independent Director | 255.4 K | 135.4 % |
| 2018 | Insmed Inc | Independent Director | 225 K | 28.6 % |
| 2018 | X4 Pharmaceuticals Inc | Independent Director | 168.1 K | -0.8 % |
| 2018 | VYNE Therapeutics Inc | Independent Director | 61.6 K | -84.9 % |
| 2017 | VYNE Therapeutics Inc | Independent Director | 408.4 K | - |
| 2017 | Insmed Inc | Independent Director | 175 K | -11.7 % |
| 2017 | X4 Pharmaceuticals Inc | Independent Director | 169.4 K | - |
| 2017 | Rhythm Pharmaceuticals Inc. | Independent Director | 108.5 K | -47.1 % |
| 2016 | Rhythm Pharmaceuticals Inc. | Independent Director | 205 K | - |
| 2016 | Insmed Inc | Independent Director | 198.3 K | 23.9 % |
| 2016 | VYNE Therapeutics Inc | Independent Director | - | - |
| 2016 | X4 Pharmaceuticals Inc | Director | - | - |
| 2015 | Insmed Inc | Independent Director | 160.0 K | 45.5 % |
| 2014 | Insmed Inc | Independent Director | 110.0 K | 500.0 % |
| 2013 | Insmed Inc | Independent Director | 18.3 K | - |